Added to YB: 2022-09-22
Pitch date: 2022-09-22
GRTX [bullish]
Galera Therapeutics, Inc.
-93.87%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer.
Market Cap
$14.1M
Pitch Price
$1.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
0.14
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
GALERA THERAPEUTICS INC GRTX
A summary for this pitch has not been created yet.
Read full article (0 min)